Funded Projects › HORIZON
HEU-EFS · HARMONISED APPROACH TO EARLY FEASIBILITY STUDIES FOR MEDICAL DEVICES IN THE EUROPEAN UNION
EU Regulations on medical devices (MDs), in-vitro diagnostics, and Health Technology Assessment envisage a harmonised lifecycle approach for clinical evidence generation of MDs. To be effective this approach requires evidence generation plan to be developed since early stages of product development, by engaging all relevant stakeholders.At present, in the EU there are no standardized procedural frameworks/guidelines/common reference standards for Early Feasibility Studies (EFS), clinical investigations allowed by ISO 14155:2020 conducted early in the development aiming to inform the product development.The ambition of the HEU-EFS project is to develop a harmonised framework for the EU EFS Program, as one integrated step of evidence generation cycle. Project objectives include: (1) conducting research/analysis on state of play (i.e., characteristics, challenges, impacts) of pre-market programs for MDs, including EFS; (2) building a sustainable network of stakeholders at EU/national level to promote/support EFS implementation; (3) developing a sound, widely applicable, harmonised EU methodology and formulating recommendations to uptake EFS; (4) undertaking pilots to test the proposed framework; (5) developing instruments to monitor the EFS performance; and (6) implementing a dedicated, sustainable, open access online portal dedicated to EFS methodological framework, best practices and network.To achieve these goals, the HEU-EFS consortium has been designed including a wide range of relevant stakeholders: research organisations, HTA bodies, patient organizations, healthcare providers, SMEs (including health technology developers, legal experts, and a CRO), and 6 major private companies that are part of a pre-identified industry consortium. An Advisory Board made of competent authorities, notified bodies, medical and biomedical engineering professional associations, networks and industry trade association will collaborate to the success of the initiative.
Consortium · 39 organisations
UNIVERSITA COMMERCIALE LUIGI BOCCONI
IT · €3,999,489
EDWARDS LIFESCIENCES GMBH
DE
AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI
IT · €575,380
QURASOFT GMBH
DE · €102,500
FOLKEHELSEINSTITUTTET
NO · €1,087,221
PHILIPPS UNIVERSITAET MARBURG
DE · €626,274
W.L. GORE & ASSOCIATI S.R.L.
IT
ABBOTT LABORATORIES LIMITED
UK
ST JUDE MEDICAL COORDINATION CENTER
BE
ABBOTT FRANCE
FR
CARMAT
FR · €112,500
REGION SYDDANMARK
DK · €313,910
MEDITRIAL S.R.L.
IT · €520,000
FORUM DES PATIENTS EUROPEENS
BE · €329,375
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
IE · €729,880
ABBOTT BV
NL
EDWARDS LIFESCIENCES LLC
US
EVALVE, INC
US
ABBOTT LABORATORIOS LDA
PT
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
FR · €725,494
EDWARDS LIFESCIENCES BV
NL
EDWARDS LIFESCIENCES SAS
FR
NEWRONIKA SPA
IT · €183,125
SOFRADIM PRODUCTION SASU
FR
IDRIS ONCOLOGY B.V.
NL · €68,450
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
ES · €419,484
EDWARDS LIFESCIENCES BELGIUM BV
BE
W L GORE & ASSOCIATES BV
NL
SYNTHES GMBH
CH
ABBOTT GMBH
DE
MEDTRONIC BAKKEN RESEARCH CENTER B.V.
NL
HOSPITAL CLINIC DE BARCELONA
ES
ABBOTT VASCULAR INTERNATIONAL
BE
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
IT · €478,500
ST JUDE MEDICAL BUSINESS SERVICES INC
US
GLOBAL HEART HUB COMPANY LIMITED BY GUARANTEE
IE · €260,616
EDWARDS LIFESCIENCES SARL
CH
PHILIPS MEDICAL SYSTEMS NEDERLAND BV
NL
ST JUDE MEDICAL CARDIOLOGY DIVISION INC
US
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.